Nonmotor Symptoms in Subjects Without Evidence of Dopaminergic Deficits

Movement Disorders

Volumn 30, Issue 7, 2015, Pages 976-981

  Sprenger, Fabienne S ^a   Seppi, Klaus ^a   Djamshidian, Atbin ^a   Reiter, Eva ^a   Nocker, Michael ^a   Mair, Katherina ^a   Göbel, Georg ^a   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Nonmotor symptoms; Parkinson's disease; SWEDDs

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; FATIGUE; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NONMOTOR SYMPTOM; ORTHOSTATIC HYPOTENSION; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SUBJECT WITHOUT EVIDENCE OF DOPAMINERGIC DEFICIT; UNIFIED PARKINSON DISEASE RATING SCALE; URINARY DYSFUNCTION; AGED; CLASSIFICATION; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; THERMOREGULATION;

AGED; BODY TEMPERATURE REGULATION; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84931957441     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26204     Document Type: Article

References (32)

1. Marek K, Jennings D, Seibyl J. Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa. Neurology 2003;61(6 Suppl 3):S43-S48.
2. Marshall VL, Reininger CB, Marquardt M, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord 2009;24:500-508.
3. Mian OS, Schneider SA, Schwingenschuh P, Bhatia KP, and Day BL. Gait in SWEDDs patients: comparison with Parkinson's disease patients and healthy controls. Mov Disord 2011;26:1266-1273.
4. Fahn S, Parkinson Study Group. Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol 2005;252(Suppl 4):IV37-IV42.
5. Marek K, Seibyl J, Eberly S, et al. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology 2014;82:1791-1797.
6. Stockner H, Schwingenschuh P, Djamshidian A, et al. Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease? Mov Disord 2012;27:1182-1185.
7. Marek K, Jennings D, Seibyl J. Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study. Neurology 2005;64:A274.
8. Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-2215.
9. Bain PG. Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs. Neurology 2009;72:1443-1445.
10. Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 2009;24:2379-2385.
11. Bajaj N. SWEDD for the general neurologist. Adv Clin Neurosci Rehabil 2010;10:30-31.
12. Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011;95:629-635.
13. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 2006;14:169-175.
14. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993;103:30-36.
15. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-381.
16. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004;19:1306-1312.
17. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 2007;22:2386-2393.
18. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry 2014;85:31-37.
19. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord 2012;27:79-83.
20. Demerdash A, Heilman K, Myers J, Mitchell C, Standaert D, Skidmore F. Neurobehavioral disorders in parkinsonian patients without dopamine deficits (SWEDD) (P2.170). Neurology 2014;82(10 Suppl):P2.170.
21. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-35.
22. Schwingenschuh P, Ruge D, Edwards MJ, et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010;25:560-569.
23. Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, et al. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 2009;80:744-748.
24. Jang W, Ahn JY, Kim HT. Non motor symptoms in PD patients with SWEDD. Mov Disord 2013;28(Suppl 1): 299.
25. Breen KC,. Drutyte G. Non-motor symptoms of Parkinson's disease: the patient's perspective. J Neural Transm 2013;120:531-535.
26. Poewe W. Non-motor symptoms in Parkinson's disease. Eur J Neurol 2008;15(Suppl 1):14-20.
27. Devanand DP, Michaels-Marston KS, Liu X, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000;157:1399-1405.
28. Panza F, Frisardi V, Capurso C, et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 2010;18:98-116.
29. Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord 2013;13:8.
30. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
31. Batla A, Erro R, Stamelou M, et al. Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study. Mov Disord 2014;29:1820-1825.
32. Lee MJ, Kim SL, Lyoo CH, Lee MS. Kinematic analysis in patients with Parkinson's disease and SWEDD. J Parkinsons Dis 2014 4:421-430.